CHI3L1 and neoplasm: Importantly, a recent study verified that human monoclonal CHI3L1 neutralizing antibodies (nAbs) inhibited the tumor growth as well as mitigated fibrosis, angiogenesis and restored immunostimulatory functions in a pancreatic cancer orthotopic mice model [45].